Based on pathway analysis, the highly enriched pathways of quercetin in treating GC were associated with the PI3k-Akt signaling, EGFR tyrosine kinase inhibitor resistance, Rap1 signaling, ErbB signaling, FoxO signaling, and Ras signaling pathways. This evidence concerns the gene AKT1 and gastric cancer.